CD22 (Pinatuzumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607794

This Humanized Monoclonal antibody specifically detects CD22 (Pinatuzumab Biosimilar) in ELISA and FACS. It exhibits reactivity toward Human.

Quick Overview for CD22 (Pinatuzumab Biosimilar) antibody (Biotin) (ABIN7607794)

Target: CD22 (Pinatuzumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD22 (Pinatuzumab Biosimilar) antibody is conjugated to Biotin

Application: ELISA, Flow Cytometry (FACS)

Product Details anti-CD22 (Pinatuzumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-CD22 (pinatuzumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for CD22 (Pinatuzumab Biosimilar)

Target: CD22 (Pinatuzumab Biosimilar)

Alternative Name: pinatuzumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD22,SIGLEC2,BL-CAM,SIGLEC-2,Siglec2,SIGLEC2FLJ22814
Synonyms Antibody:ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000